Loading...
skip to Main Content

💻Join us today for a new episode of the #EASLstudio.

➡️LIVE, from 18:00 CET, our experts will discuss the key goals of the EASL-@TheLancet Liver Commission.

@EASLedu @JHepatology @aelsharkawy75 @AleksanderKrag @tomhemmingk

https://easl.eu/easl-studio/

📢 #LiverTwitter, today is D-Day for your abstract on #viralhepatitis for our #EASLspecial meeting in Feb 2022.

⏰ Deadline to submit your abstract: Midnight, 23:59 CET

@EASLedu @JHepatology @aelsharkawy75

https://easl.eu/event/viral-hepatitis-elimination-2022/abstract-information/

Webcast description

In the rapidly developing field of COVID-19 virology, Professor Darius Moradpour hosts this update to our current understanding of SARS-CoV-2 infection, supported by three world-renowned experts looking at the major challenges that lie ahead.

Although multiple vaccines have now been approved, one of the most important ongoing complications of the SARS-CoV-2 pandemic will be to monitor and adapt to the emergence of new variants. In this webcast, the experts explore current understanding of coronavirus evolution, which can lead to antigenic drift and the potential for immune escape, and discuss the possible implications for transmission and human health.

Looking at the clinical characteristics of SARS-CoV-2 infection, the experts also discuss ongoing progress in the use of antiviral therapy, the evidence around SARS-CoV-2 infection in hepatocytes and liver injury, and special considerations in immunosuppressed patients.

Moderator: Darius Moradpour
Panel:
  • Sandra Ciesek
  • Jan Felix Drexler
  • Volker Thiel

Learning objectives

  • Understand the evolution of coronaviruses, including antigenic drift and the potential for immune escape
  • Learn about the possible implications for transmission and human health
  • Understand the clinical characteristics of SARS-CoV-2 infection
  • Learn about the currently used antiviral therapy
  • Learn about SARS-CoV-2 infection in hepatocytes and the consequences on liver injury

Target audience

  • General practitioners
  • Hepatologists
  • Health care professionals
  • Clinical researchers and scientists

💻Join us today for a new episode of the #EASLstudio.

➡️LIVE, from 18:00 CET, our experts will discuss the key goals of the EASL-@TheLancet Liver Commission.

@EASLedu @JHepatology @aelsharkawy75 @AleksanderKrag @tomhemmingk

https://easl.eu/easl-studio/

📢 #LiverTwitter, today is D-Day for your abstract on #viralhepatitis for our #EASLspecial meeting in Feb 2022.

⏰ Deadline to submit your abstract: Midnight, 23:59 CET

@EASLedu @JHepatology @aelsharkawy75

https://easl.eu/event/viral-hepatitis-elimination-2022/abstract-information/

Back To Top